Lebenthal Global Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.56M Buy
4,759
+530
+13% +$165K 0.21% 82
2026
Q2
$1.83M Buy
4,229
+47
+1% +$14.3K 0.25% 71
2026
Q1
$894K Buy
4,182
+2,317
+124% +$518K 0.13% 121
2025
Q4
$319K Buy
+1,865
New +$290K 0.05% 168
2023
Q1
– Sell
-5,680
Closed -$239K – 125
2022
Q4
$239K Buy
5,680
+160
+3% +$6.69K 0.08% 119
2022
Q3
$202K Sell
5,520
-150
-3% -$6.68K 0.09% 110
2022
Q2
$241K Buy
5,670
+70
+1% +$3.33K 0.12% 115
2022
Q1
$301K Sell
5,600
-730
-12% -$42.5K 0.13% 115
2021
Q4
$455K Buy
+6,330
New +$397K 0.18% 87
2021
Q1
– Sell
-2,860
Closed -$135K – 363
2020
Q4
$135K Buy
+2,860
New +$120K 0.1% 133

Other funds holding LRCX

Lebenthal Global Advisors's LRCX Position: Q3 2026 in Review

Lebenthal Global Advisors increased its Lam Research (LRCX) stake by 13% in Q3 2026, buying an estimated $165K and bringing the position to 4,759 shares worth $1.56M. The position accounts for 0.21% of the portfolio, ranked #82.

Lebenthal Global Advisors first reported a position in LRCX in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.83M in Q2 2026. 2,312 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Lebenthal Global Advisors held 4,759 shares of Lam Research worth $1.56M as of Q3 2026.
  • Lebenthal Global Advisors bought 530 Lam Research shares in Q3 2026, an estimated $165K.
  • Lam Research made up 0.21% of Lebenthal Global Advisors's portfolio in Q3 2026, its #82 holding.
  • Lebenthal Global Advisors first reported a position in Lam Research in Q4 2020 and has held it in 10 quarters since.
  • Lebenthal Global Advisors's Lam Research position peaked at $1.83M in Q2 2026.
  • 2,312 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Lebenthal Global Advisors's 13F filing for Q3 2026, filed 28 Oct 2026.